secwatch.observer — SEC 8-K summary
======================================

Issuer:     INVIVO THERAPEUTICS HOLDINGS CORP. (—)
CIK:        0001292519
Form:       8-K
Filed at:   2024-02-01T23:59:59+00:00
Accession:  0001104659-24-009146
Event type: other_material
Sentiment:  negative
Materiality: 1.00
Item codes: 1.03
LLM model:  deepseek-v4-flash:cloud@v2

InVivo Therapeutics files Chapter 11 bankruptcy, seeks asset sale
-----------------------------------------------------------------

- Filed voluntary Chapter 11 petitions on Feb 1, 2024 in Delaware Bankruptcy Court.
- Will operate as debtor-in-possession; filed motions for continued business practices and potential asset sale.
- Case administered under 'In re InVivo Therapeutics Holdings Corp., et al.'; claims agent is Kurtzman Carson Consultants.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1292519/000110465924009146/0001104659-24-009146-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1292519/000110465924009146/tm244807d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-009146

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer